Teradyne price target raised to $350 from $300 at Goldman Sachs

Goldman Sachs raised the firm’s price target on Teradyne (TER) to $350 from $300 and keeps a Buy rating on the shares. Teradyne reported a strong quarter that was likely overshadowed by high expectations and an already significant year-to-date stock rally, despite robust underlying demand trends in semiconductor test markets, the analyst tells investors in a research note. Management highlighted sustained strength in compute and memory testing, including HBM/DRAM, alongside the announcement of a new merchant GPU customer, which reinforces the company’s positioning in AI-driven test demand even as revenue timing remains somewhat uneven, the firm says.